A detailed history of South Dakota Investment Council transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, South Dakota Investment Council holds 16,088 shares of HALO stock, worth $684,866. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,088
Previous 16,088 -0.0%
Holding current value
$684,866
Previous $842,000 9.38%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$36.46 - $44.03 $993,097 - $1.2 Million
-27,238 Reduced 62.87%
16,088 $615,000
Q1 2022

May 10, 2022

SELL
$31.97 - $41.06 $920,736 - $1.18 Million
-28,800 Reduced 39.93%
43,326 $1.73 Million
Q2 2021

Aug 11, 2021

BUY
$38.84 - $51.31 $640,860 - $846,615
16,500 Added 29.66%
72,126 $3.28 Million
Q1 2021

May 13, 2021

BUY
$39.51 - $51.45 $2.2 Million - $2.86 Million
55,626 New
55,626 $2.32 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $5.93B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.